SummaryWe have previously reported that chicken egg white (EW) and low-allergenic EW hydrolysate (EWH) suppressed ectopic fat accumulation and improved serum glucose and insulin levels. In this study, the dietary effects of EW and EWH on glucose tolerance were investigated in different ways to clarify the effect of EW and EWH on intestinal glucose absorption. Type 2 diabetic Nagoya-Shibata-Yasuda mice were divided into four groups: a low-fat and low-sucrose casein-based diet group (NL); high-fat and high-sucrose (HFS) casein-based diet group (NH); HFS EW-based diet group (NE); and HFS EWH-based diet group (NEH). Mice were fed their respective diets for 8 wk. At the end of the 6th and 7th week, an oral glucose tolerance test (OGTT) and insulin tolerance test (ITT) were respectively conducted in experiment A. At the end of the 7th week, an intraperitoneal glucose tolerance test (ipGTT) was conducted in experiment B. In experiment A, the plasma glucose level was suppressed in the NE group during both OGTT and ITT, and suppressed in the NEH group during OGTT, but not during ITT. In experiment B, the plasma glucose level was similarly suppressed in the NEH group during ipGTT, but the suppressive effect was weakened compared to OGTT. Plasma insulin level was lower in the NE and NEH groups in both experiments. Fecal triacylglycerol excretion was increased in the NE and NEH groups in experiment A and liver triacylglycerol content was suppressed in the NE group in experiment B. These findings suggested that in addition to improving fat metabolism, EWH improves glucose tolerance via mechanisms related and unrelated to small intestinal function. Key Words egg white hydrolysate, glucose tolerance, oral administration, intraperitoneal injection, Nagoya-Shibata-Yasuda mice Chicken egg white (EW) makes up about 60% of the whole egg weight and contains proteins high in amino acid balance. EW has been reported to suppress food intake, dietary fat absorption, and fat accumulation in rats in our previous studies (1-3); therefore, EW can be considered for the prevention and treatment of obesity and type 2 diabetes mellitus (T2DM) in humans. However, egg-specific proteins in EW are well known to be major allergens in humans. Continuous consumption of EW or whole egg can induce allergic symptoms in humans; therefore, it is necessary to produce low-allergenic EW products. Recently, low-allergenic bioactive peptides derived from EW have been developed and purified for the prevention and improvement of several metabolic disorders such as hypertension and oxidative stress (4-6). However, few studies have reported the effects of low-allergenic EW products on glucose metabolism.We previously developed EW enzymatic hydrolysate (EWH), which contains less allergenic proteins and has similar physicochemical properties to EW (3). We have also reported that EWH improves fasting serum glucose and insulin levels in diabetic Goto-Kakizaki (GK) rats (1) and Wistar rats (2). These findings suggest that in addition to improving fat metabolism, EWH can...